VAG
GILD icon

VisionPoint Advisory Group’s Gilead Sciences GILD Stock Holding History

VisionPoint Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$756K Buy
5,982
+1,216
+26% +$160K 0.12% 191
2026
Q1 		$664K Sell
4,766
-1,761
-27% -$247K 0.13% 187
2025
Q4 		$801K Buy
6,527
+1,672
+34% +$203K 0.16% 151
2025
Q3 		$539K Buy
4,855
+491
+11% +$55.8K 0.11% 198
2025
Q2 		$484K Buy
+4,364
New +$464K 0.11% 191
2024
Q2 		– Sell
-29
Closed -$2.12K – 841
2024
Q1 		$2.12K Hold
29
– – ﹤0.01% 675
2023
Q4 		$2.35K Buy
+29
New +$2.26K ﹤0.01% 599

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

VisionPoint Advisory Group's GILD Position: Q2 2026 in Review

VisionPoint Advisory Group increased its Gilead Sciences (GILD) stake by 26% in Q2 2026, buying an estimated $160K and bringing the position to 5,982 shares worth $756K. The position accounts for 0.12% of the portfolio, ranked #191.

VisionPoint Advisory Group first reported a position in GILD in Q4 2023 and has held it in 7 quarters since. The position peaked at $801K in Q4 2025. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • VisionPoint Advisory Group held 5,982 shares of Gilead Sciences worth $756K as of Q2 2026.
  • VisionPoint Advisory Group bought 1,216 Gilead Sciences shares in Q2 2026, an estimated $160K.
  • Gilead Sciences made up 0.12% of VisionPoint Advisory Group's portfolio in Q2 2026, its #191 holding.
  • VisionPoint Advisory Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 7 quarters since.
  • VisionPoint Advisory Group's Gilead Sciences position peaked at $801K in Q4 2025.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.